Outsourced Pharma Capacity Update | July 2023

Kevin Yarnall, Sr. Manager, Manufacturing, presented Emergent's manufacturing capabilities and available capacity at its Rockville, Maryland drug product facility during the Outsourced Pharma Capacity Webinar in June. If you missed the live presentation, watch ondemand to learn how Emergent is equipped to support the scale-up and CGMP manufacturing for your next clinical or commercial therapy.

WATCH THE WEBINAR

OPCU Webinar - JUN2023 - Cover Image

 

On Demand Webinar: High-Speed Viral Drug Product Manufacturing

Our viral drug product manufacturing facility in Rockville, MD is home to our INTEGRA® high-speed bulk filling line, with fully...

READ MORE

Emergent BioSolutions to Invest $75 Million in Canton Site and Expand Viral Vector and Gene Therapy Capability

  • Company acquires property adjacent to its Canton, Massachusetts live viral drug substance development and manufacturing...
READ MORE

4 Steps for a Smooth Tech Transfer When Working with a CDMO

In our recent article with BioPharma Dive, Emergent's Shelly Buhay, Director of MS&T and Dan Perrin, Director of Manufacturing...

READ MORE